PHF23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.916600E-01
Normal-vs-Stage2
3.693600E-01
Normal-vs-Stage3
2.993800E-01
Normal-vs-Stage4
8.050200E-01
Stage1-vs-Stage2
9.970200E-01
Stage1-vs-Stage3
5.561200E-01
Stage1-vs-Stage4
6.773800E-01
Stage2-vs-Stage3
4.405600E-01
Stage2-vs-Stage4
5.648400E-01
Stage3-vs-Stage4
4.751200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.090800E-01
Normal-vs-AfricanAmerican
4.337400E-01
Normal-vs-Asian
2.763600E-01
Caucasian-vs-AfricanAmerican
8.868400E-01
Caucasian-vs-Asian
9.787000E-01
AfricanAmerican-vs-Asian
8.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.134400E-01
Normal-vs-Female
5.383800E-01
Male-vs-Female
2.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.583600E-01
Normal-vs-Age(41-60Yrs)
9.087000E-01
Normal-vs-Age(61-80Yrs)
2.154800E-01
Normal-vs-Age(81-100Yrs)
3.134000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.272600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.524200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.742400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.171560E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.497810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.904400E-01
Normal-vs-Daily Drinker
1.265380E-01
Normal-vs-Weekly Drinker
9.746800E-01
Normal-vs-Occasional Drinker
4.288000E-01
Normal-vs-Social Drinker
2.185200E-01
Non Drinker-vs-Daily Drinker
7.266800E-01
Non Drinker-vs-Weekly Drinker
1.035390E-01
Non Drinker-vs-Occasional Drinker
2.390600E-01
Non Drinker-vs-Social Drinker
2.435400E-01
Daily Drinker-vs-Weekly Drinker
9.626100E-02
Daily Drinker-vs-Occasional Drinker
7.964100E-02
Daily Drinker-vs-Social Drinker
8.792400E-02
Weekly Drinker-vs-Occasional Drinker
4.643200E-01
Weekly Drinker-vs-Social Drinker
3.703400E-01
Occasional Drinker-vs-Social Drinker
7.710600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.621000E-01
Normal-vs-Grade 2
8.486200E-01
Normal-vs-Grade 3
8.412400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.806800E-01
Grade 1-vs-Grade 3
5.705400E-01
Grade 1-vs-Grade 4
8.621000E-01
Grade 2-vs-Grade 3
7.780400E-01
Grade 2-vs-Grade 4
8.486200E-01
Grade 3-vs-Grade 4
8.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.326800E-01
Normal-vs-NonDiabetic
4.479000E-01
Diabetic-vs-NonDiabetic
1.906390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.927600E-01
Normal-vs-NoPancreatitis
3.770000E-01
Pancreatitis-vs-NoPancreatitis
5.634000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.831200E-01
Normal-vs-N1
4.499400E-01
N0-vs-N1
7.615000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.391800E-02
Normal-vs-TP53-NonMutant
3.334800E-01
TP53-Mutant-vs-TP53-NonMutant
2.316300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
